Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | SI | P14410 | 2/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 5/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15513264 | 1.00 | MGAM (0.41) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL26517483 | 0.88 | MGAM (0.35) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL26517478 | 0.88 | MGAM (0.35) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL8751683 | 0.86 | MGAM (0.50) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL13523602 | 0.85 | FAAH (0.39) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL28153515 | 0.84 | TSHR (0.44) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL25464992 | 0.82 | MGAM (0.43) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL28034880 | 0.82 | FAAH (0.33) | MGAMGAASIMGAM2FAAH | |
| SCHEMBL1171910 | 0.82 | GAA (0.46) | MGAMGAASIMGAM2CHRNB2 | |
| SCHEMBL18154853 | 0.82 | ALOX15 (0.47) | MGAMGAASIMGAM2CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304523-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | AARHUS UNIVERSITET (DK) | 2025-10-02 | — | — | US | claimed |
| EP-4519239-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | Aarhus Universitet (DK) | 2025-03-12 | — | — | EP | claimed |
| US-11890264-B2 | Migraine prevention and treatment | UNIVERSITATS-KINDERSPITAL BEIDER BASEL (CH) | 2024-02-06 | — | — | US | claimed |
| US-20230399288-A1 | LACTATE/KETONE BODY ESTERS | AARHUS UNIVERSITET (DK) | 2023-12-14 | — | — | US | claimed |
| WO-2023213874-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | AARHUS UNIVERSITET (DK) | 2023-11-09 | — | — | WO | claimed |
| US-20230285348-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA | 2023-09-14 | — | — | US | claimed |
| EP-4240345-A1 | LACTATE/KETONE BODY ESTERS | Aarhus Universitet (DK) | 2023-09-13 | — | — | EP | claimed |
| CN-116528848-A | Lactic acid/ketone body esters | 奥胡斯大学 | 2023-08-01 | — | — | CN | claimed |
| US-20230172891-A1 | PREVENTION AND TREATMENT OF EFFECTS OF AGING AND AGE-ASSOCIATED DISORDERS WITH KETONE SUPPLEMENTATION | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2023-06-08 | — | — | US | claimed |
| US-11596616-B2 | Compositions and methods for weight loss maintenance | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-03-07 | — | — | US | claimed |
| WO-2022096637-A1 | LACTATE/KETONE BODY ESTERS | AARHUS UNIVERSITET (DK) | 2022-05-12 | — | — | WO | claimed |
| US-20210338618-A1 | MIGRAINE PREVENTION AND TREATMENT | UNIVERSITATS-KINDERSPITAL BEIDER BASEL (CH) | 2021-11-04 | — | — | US | claimed |
| WO-2021150928-A1 | PREVENTION AND TREATMENT OF EFFECTS OF AGING AND AGE-ASSOCIATED DISORDERS WITH KETONE SUPPLEMENTATION | UNIVERSITY OF SOUTH FLORIDA (US) | 2021-07-29 | — | — | WO | claimed |
| US-20200397736-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA | 2020-12-24 | — | — | US | claimed |
| EP-3723511-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | University of South Florida (US) | 2020-10-21 | — | — | EP | claimed |
| WO-2019118624-A1 | COMPOSITIONS AND METHODS FOR WEIGHT LOSS MAINTENANCE | UNIVERSITY OF SOUTH FLORIDA (US) | 2019-06-20 | — | — | WO | claimed |
| US-20250320175-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-10-16 | — | — | US | disclosed |
| US-20250304523-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | AARHUS UNIVERSITET (DK) | 2025-10-02 | — | — | US | disclosed |
| US-5349026-A | To form a tough film from aqueous dispersion of vinyl or arylic polymer | ROHM AND HAAS COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| EP-0599478-A1 | Coating composition | ROHM AND HAAS COMPANY (US) | 1994-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399288-A1 | LACTATE/KETONE BODY ESTERS | LDHB, LDHA, IL1B | MGAM 622/4885GAA 1759/4885SI 349/4885 |
| US-20250304523-A1 | COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE | LDHB, LDHA, LCT | MGAM 371/4885GAA 1663/4885SI 241/4885 |
| US-20210338618-A1 | MIGRAINE PREVENTION AND TREATMENT | ACACA, ACACB, HBB | MGAM 2155/4885GAA 751/4885SI 906/4885 |
| US-11890264-B2 | Migraine prevention and treatment | ACACA, ACACB, HBB | MGAM 2155/4885GAA 751/4885SI 906/4885 |
| US-20250320175-A1 | Acetoacetate Based Ketals | KYAT1, KAT5, ALDOA | MGAM 274/4885GAA 775/4885SI 854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.